A detailed history of Bogart Wealth, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Bogart Wealth, LLC holds 40 shares of FLGT stock, worth $714. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 40 -0.0%
Holding current value
$714
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$23.64 - $30.27 $709 - $908
-30 Reduced 42.86%
40 $1,000
Q4 2022

Feb 06, 2023

BUY
$29.23 - $40.28 $1,169 - $1,611
40 Added 133.33%
70 $2,000
Q1 2022

Apr 22, 2022

BUY
$49.85 - $96.11 $498 - $961
10 Added 50.0%
30 $2,000
Q2 2021

Aug 06, 2021

BUY
$66.8 - $100.45 $1,336 - $2,009
20 New
20 $2,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $541M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Bogart Wealth, LLC Portfolio

Follow Bogart Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bogart Wealth, LLC with notifications on news.